Trials / Completed
CompletedNCT00939185
Compliance And Safety Study In Children With Upper And Lower Respiratory Tract Infections
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 400 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 1 Year – 14 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to obtain data on the safety, tolerability and compliance with Zithromax in children with bacterial infections of the upper and lower respiratory tract.
Detailed description
Patients were recruited from the outpatient departments of the participating sites/hospitals/clinics.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Azithromycin | Zithromax was dispensed according to the Summary of Product Characteristics (SPC) as either a tablet or suspension. Zithromax was administered as a total dose of 30 mg/kg which was given as single daily doses of 10 mg/kg for 3 days, or as a 5 day dose starting with 10 mg/kg on Day 1, then 5 mg/kg on Days 2-5. |
Timeline
- Start date
- 2007-04-01
- Primary completion
- 2009-01-01
- Completion
- 2009-01-01
- First posted
- 2009-07-14
- Last updated
- 2010-03-30
- Results posted
- 2010-03-18
Source: ClinicalTrials.gov record NCT00939185. Inclusion in this directory is not an endorsement.